Opening book details…
Can I read Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan on EtoBox?
Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan by Cheng-Kuo Cheng; Shih-Jen Chen; Jiann-Torng Chen; Lee-Jen Chen; San-Ni Chen; Wen-Lu Chen; Sheng-Min Hsu; Chien-Hsiung Lai; Shwu-Jiuan Sheu; Pei-Chang Wu; Wei-Chi Wu; Wen-Chuan Wu; Chung-May Yang; Ling Yeung; Ta-Ching Chen; Chang-Hao Yang is a Medicine article available to read on EtoBox.
What is Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan about?
## Abstract The management of neovascular age-related macular degeneration (nAMD) has taken a major stride forward with the advent of anti-VEGF agents. The treat-and-extend (T&E) approach is a refined management strategy, tailoring to the individual patient’s disease course and treatment outcome. To provide guidance to implementing anti-VEGF T&E regimens for nAMD in resource-limited health care systems, an advisory board was held to discuss and generate expert consensus, based on local and international guidelines, current evidence, as well as local experience and reimbursement policies. In the experts’ opinion, treatment of nAMD should aim to maximize and maintain visual acuity benefits while minimizing treatment burden. Based on current evidence, treatment could be initiated with 3 consecutive monthly injections. After the initial period, treatment interval may be extended by 2 or 4 weeks each time for the qualified patients (i.e. no BCVA loss ≥5 ETDRS letters and dry retina), and a maximum interval of 16 weeks is permitted. For patients meeting the shortening criteria (i.e. any increased fluid with BCVA loss ≥5 ETDRS letters, or presence of new macular hemorrhage or new neovascu
Who reads Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Cheng-Kuo Cheng; Shih-Jen Chen; Jiann-Torng Chen; Lee-Jen Chen; San-Ni Chen; Wen-Lu Chen; Sheng-Min Hsu; Chien-Hsiung Lai; Shwu-Jiuan Sheu; Pei-Chang Wu; Wei-Chi Wu; Wen-Chuan Wu; Chung-May Yang; Ling Yeung; Ta-Ching Chen; Chang-Hao Yang
- Publisher
- Springer Science and Business Media LLC
- Published
- 2022
- Language
- EN
- Field
- Medicine (Health Sciences)